Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-28053515

RESUMEN

T lymphocytes are believed to play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). How T cells are recruited to the lungs and contribute to the inflammatory process is largely unknown. COPD is a heterogeneous disease, and discriminating disease phenotypes based on distinct molecular and cellular pathways may provide new approaches for individualized diagnosis and therapies. Bronchoalveolar lavage (BAL) and blood samples were obtained from 40 never-smokers, 40 smokers with normal lung function, and 38 COPD patients. T-cell chemokine receptor expression was analyzed with flow cytometry, and soluble BAL cytokines and chemokines were measured using a cytokine multiplex assay. Correlations with gender and clinical characteristics including lung imaging were investigated using multivariate modeling. Th1/Tc1- and Th2/Tc2-associated soluble analytes and T-cell chemokine receptors were analyzed as cumulative Th1/Tc1 and Th2/Tc2 immune responses. A higher expression of chemokine receptor CCR5 on CD8+ T cells in BAL and higher percentage of CXCR3+CD8+ T cells in blood was found in female smokers with COPD compared to those without COPD. CCR5 expression on CD4+ and CD8+ T cells was lower in BAL from male smokers with COPD compared to those without COPD. Among female smokers with COPD, Th1/Tc1 immune response was linked to BAL macrophage numbers and goblet cell density, and Th2/Tc2 response was associated with the measures of emphysema on high-resolution computed tomography. The highly gender-dependent T-cell profile in COPD indicates different links between cellular events and clinical manifestations in females compared to males. Our findings may reveal mechanisms of importance for the difference in clinical course in female COPD patients compared to males.


Asunto(s)
Disparidades en el Estado de Salud , Pulmón/inmunología , Enfermedad Pulmonar Obstructiva Crónica/inmunología , Subgrupos de Linfocitos T/inmunología , Adulto , Anciano , Biomarcadores/análisis , Líquido del Lavado Bronquioalveolar/inmunología , Estudios de Casos y Controles , Citocinas/análisis , Femenino , Humanos , Mediadores de Inflamación/análisis , Pulmón/fisiopatología , Masculino , Persona de Mediana Edad , Fenotipo , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Receptores de Quimiocina/análisis , Factores de Riesgo , Factores Sexuales , Fumar/efectos adversos , Fumar/inmunología , Balance Th1 - Th2
2.
Clin Immunol ; 169: 114-120, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27339331

RESUMEN

Cigarette smoking is a risk factor for multiple sclerosis (MS), and the risk is further multiplied for HLA-DRB1*15(+) smokers. To define the smoke-induced immune responses in the lung we performed bronchoscopy with bronchoalveolar lavage (BAL) on smokers and non-smokers, both MS-patients and healthy volunteers. In the BAL, non-smokers with MS showed an increased preformed CD40L expression in CD4(+) T-cells while smokers displayed an increase in proliferating (Ki-67(+)) T-cells. In addition, our results confirm that smoking induces an increase of alveolar macrophages in BAL, and further defined a significant attenuation of this response in carriers of the HLA-DRB1*15 allele, in both MS patients and healthy controls. This first systematic investigation of the immune response in the lungs of smokers and non-smokers diagnosed with MS, thus suggests an MS-associated lung T-cell phenotype, involvement of a specific T-cell response to smoke, and a genetic regulation of the macrophage response.


Asunto(s)
Cadenas HLA-DRB1/inmunología , Pulmón/inmunología , Esclerosis Múltiple/inmunología , Fumar/inmunología , Linfocitos T/inmunología , Adulto , Alelos , Líquido del Lavado Bronquioalveolar/citología , Líquido del Lavado Bronquioalveolar/inmunología , Broncoscopía , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Ligando de CD40/inmunología , Ligando de CD40/metabolismo , Femenino , Citometría de Flujo , Cadenas HLA-DRB1/genética , Humanos , Antígeno Ki-67/inmunología , Antígeno Ki-67/metabolismo , Modelos Lineales , Pulmón/metabolismo , Pulmón/fisiopatología , Activación de Linfocitos/inmunología , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/metabolismo , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/genética , Esclerosis Múltiple/metabolismo , Factores de Riesgo , Fumar/genética , Linfocitos T/metabolismo , Adulto Joven
3.
Proteins ; 65(2): 266-73, 2006 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-16948159

RESUMEN

The implementation of generic and efficient technologies for the production of recombinant eukaryotic proteins remains an outstanding challenge in structural genomics programs. We have recently developed a new method for rapid identification of soluble protein expression in E. coli, the colony filtration blot (CoFi blot). In this study, the CoFi blot was used to screen libraries where the N-terminal translation start point was randomized. To investigate the efficiency of this strategy, we have attributed a large number of proteins to this process. In a set of 32 mammalian proteins, we were able to double the success rate (from 34 to 68%) of producing soluble and readily purifiable proteins in E. coli. Most of the selected constructs had their N-termini close to predicted domain borders and the method therefore provides a mean for experimental "domain foot printing." Surprisingly, for most of the targets, we also observed expressing constructs that were close to full-length. In summary this strategy constitutes a generic and efficient method for producing mammalian proteins for structural and functional studies.


Asunto(s)
Escherichia coli/metabolismo , Biblioteca de Genes , Proteínas Recombinantes/metabolismo , Clonación Molecular , Escherichia coli/genética , Humanos , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Solubilidad
4.
Acta Crystallogr D Biol Crystallogr ; 60(Pt 4): 775-6, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15039583

RESUMEN

Pseudouridine, the 5-ribosyl isomer of uridine, is the most common modification of structural RNA. The recently identified pseudouridine synthase TruD belongs to a widespread class of pseudouridine synthases without significant sequence homology to previously known families. TruD from Escherichia coli was overexpressed, purified and crystallized. The crystals diffract to a minimum Bragg spacing of 2.4 A and belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 63.4, b = 108.6, c = 111.7 A.


Asunto(s)
Cristalización , Proteínas de Escherichia coli/química , Transferasas Intramoleculares/química , Clonación Molecular , Cristalografía por Rayos X , Hidroliasas/química
5.
Neuroreport ; 13(15): 1857-60, 2002 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-12395079

RESUMEN

The Arctic amyloid precursor protein (APP) Alzheimer mutation, is located inside the beta-amyloid (Abeta) domain. Here, hybrid APP mutants containing both the Swedish and the Arctic APP mutations were investigated. ELISA measurements of cell media showed decreased levels of both Abeta40 and Abeta42. Similar results were obtained for the Dutch and Italian mutations, whereas the Flemish mutation displayed increased amounts of Abeta40 and Abeta42. Immunoprecipitation studies revealed increased Abeta40/p3 and Abeta42/p3 ratios for the Arctic mutation. These results were further verified by quantification revealing decreased levels of alphaAPPs accompanied by increased betaAPPs levels in the media. Thus, the pathogenic effects of the Arctic mutation may not only be due to the changed properties of the peptide but also altered processing of Arctic APP.


Asunto(s)
Enfermedad de Alzheimer/genética , Péptidos beta-Amiloides/genética , Precursor de Proteína beta-Amiloide/genética , Química Encefálica/genética , Encéfalo/metabolismo , Mutación/genética , Fragmentos de Péptidos/genética , Enfermedad de Alzheimer/metabolismo , Secretasas de la Proteína Precursora del Amiloide , Péptidos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Regiones Árticas , Ácido Aspártico Endopeptidasas/genética , Ácido Aspártico Endopeptidasas/metabolismo , Encéfalo/fisiopatología , Células Cultivadas , Medios de Cultivo/metabolismo , Regulación hacia Abajo/genética , Endopeptidasas/genética , Endopeptidasas/metabolismo , Regulación de la Expresión Génica/genética , Humanos , Fragmentos de Péptidos/metabolismo , Regulación hacia Arriba/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...